RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307).
Saeki H, Jogo T, Kawazoe T, Kamori T, Nakaji Y, Zaitsu Y, Fujiwara M, Baba Y, Nakamura T, Iwata N, Egashira A, Nakanoko T, Morita M, Tanaka Y, Kimura Y, Shibata T, Nakashima Y, Emi Y, Makiyama A, Oki E, Tokunaga S, Shimokawa M, Mori M; Kyushu Study Group of Clinical Cancer (KSCC).
Saeki H, et al. Among authors: kamori t.
Ann Surg. 2022 Apr 1;275(4):692-699. doi: 10.1097/SLA.0000000000003975.
Ann Surg. 2022.
PMID: 32482981